Literature DB >> 11777765

Catheter angiography and angioplasty in patients with scleroderma.

E A Dick1, R Aviv, I Francis, G Hamilton, D Baker, C Black, A Platts, A Watkinson.   

Abstract

The objectives of this study were (i) to identify patterns of angiographic disease in scleroderma patients with and without other vascular risk factors and (ii) to define patients with scleroderma in whom angiography and angioplasty is useful. The records of 26 patients with scleroderma who underwent angiography and angioplasty over an 8-year period were reviewed. Angiographic disease patterns were assessed using a modified Brewster classification. Angiography of the upper limb demonstrated distal disease alone in 86% of patients, both with and without other vascular risk factors such as smoking. In the lower limb there was a highly significant association between the presence of other vascular risk factors and macrovascular disease potentially amenable to angioplasty, and conversely between the absence of other vascular risk factors and distal disease in the lower limb. Good early but poor late clinical results were achieved in three of five patients who underwent angioplasty. Angiography of the upper limb is likely to demonstrate distal disease alone, and angiography and angioplasty of the lower limb may be useful only if other vascular risk factors are present.

Entities:  

Mesh:

Year:  2001        PMID: 11777765     DOI: 10.1259/bjr.74.888.741091

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  6 in total

Review 1.  Cardiovascular disease in systemic sclerosis.

Authors:  Francesca Cannarile; Valentina Valentini; Giulia Mirabelli; Alessia Alunno; Riccardo Terenzi; Filippo Luccioli; Roberto Gerli; Elena Bartoloni
Journal:  Ann Transl Med       Date:  2015-01

2.  Lipoprotein profile in limited systemic sclerosis.

Authors:  Eduardo F Borba; Claudia T L Borges; Eloísa Bonfá
Journal:  Rheumatol Int       Date:  2005-02-08       Impact factor: 2.631

3.  Independent association of anti-beta(2)-glycoprotein I antibodies with macrovascular disease and mortality in scleroderma patients.

Authors:  Francesco Boin; Stefano Franchini; Elizabeth Colantuoni; Antony Rosen; Fredrick M Wigley; Livia Casciola-Rosen
Journal:  Arthritis Rheum       Date:  2009-08

Review 4.  Cardiovascular disease in systemic sclerosis--an emerging association?

Authors:  Gene-Siew Ngian; Joanne Sahhar; Ian P Wicks; Sharon Van Doornum
Journal:  Arthritis Res Ther       Date:  2011-08-26       Impact factor: 5.156

5.  Total Percutaneous Revascularization of the Hand to Treat Refractory Digital Ischemia in Advanced Systemic Sclerosis.

Authors:  Kevin A Honan; Lily Romero-Karam; Maureen Mayes; Salman A Arain
Journal:  JACC Case Rep       Date:  2022-02-02

6.  No effects of bosentan on microvasculature in patients with limited cutaneous systemic sclerosis.

Authors:  Martha E Hettema; Dan Zhang; Ymkje Stienstra; Andries J Smit; Hendrika Bootsma; Cees G M Kallenberg
Journal:  Clin Rheumatol       Date:  2009-04-07       Impact factor: 2.980

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.